EW vs PLXS · P/E 47, rev $3.39B vs P/E 43, rev $4.03B
Edwards Lifesciences Corp (EW) versus Plexus Corp (PLXS) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Plexus Corp (PLXS) is a electronic components company listed on NASDAQ.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported PLXS revenue for 2025-09-27 was $4.03B. Net income was $172.9M. PLXS currently screens at market cap $7.87B and trailing P/E 43.0.
EW currently screens at market cap $49.91B and trailing P/E 46.9. PLXS currently screens at market cap $7.87B and trailing P/E 43.0.
Not investment advice. Open the EW and PLXS stock pages for the full models.
Not investment advice.